StockData
Biogen Inc. logo

Biogen Inc. (BIIB) stock

BIIBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3058% above fair value
$249.59+2.46 (+1.00%)

Close on Nov 20, 2026Market cap $36.89BP/E 106.7Yield –

Biogen shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Biogen's shares outstanding was 148M at Sep 30, 2026. For fiscal 2025 it was 147M, up 0.8% from the year before. Over ten years it grew -4.4% a year on average. The highest annual figure on record is 320M in fiscal 2007.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025147M+0.8%
FY2024Dec 31, 2024146M+0.2%
FY2023Dec 31, 2023146M-0.3%
FY2022Dec 31, 2022146M-2.4%
FY2021Dec 31, 2021150M-7.3%
FY2020Dec 31, 2020161M-13.9%
FY2019Dec 31, 2019187M-8.7%
FY2018Dec 31, 2018205M-3.6%
FY2017Dec 31, 2017213M-2.7%
FY2016Dec 31, 2016219M-5.4%
FY2015Dec 31, 2015231M-2.5%
FY2014Dec 31, 2014237M-0.5%
FY2013Dec 31, 2013238M-0.6%
FY2012Dec 31, 2012240M-2.2%
FY2011Dec 31, 2011245M-3.9%
FY2010Dec 31, 2010255M-12.0%
FY2009Dec 31, 2009289M-1.9%
FY2008Dec 31, 2008295M-7.9%
FY2007Dec 31, 2007320M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026148M+0.5%
Q2 FY2026Jun 30, 2026149M+1.4%
Q1 FY2026Mar 31, 2026148M+1.2%
Q4 FY2025Dec 31, 2025148M+1.6%
Q3 FY2025Sep 30, 2025147M+0.7%
Q2 FY2025Jun 30, 2025147M+0.5%
Q1 FY2025Mar 31, 2025147M+0.5%
Q4 FY2024Dec 31, 2024146M-0.2%
Q3 FY2024Sep 30, 2024146M+0.9%
Q2 FY2024Jun 30, 2024146M+0.3%
Q1 FY2024Mar 31, 2024146M+0.5%
Q4 FY2023Dec 31, 2023146M+0.3%
Q3 FY2023Sep 30, 2023145M0.0%
Q2 FY2023Jun 30, 2023146M-0.5%
Q1 FY2023Mar 31, 2023145M-1.6%
Q4 FY2022Dec 31, 2022145M-1.4%
Q3 FY2022Sep 30, 2022145M-2.6%
Q2 FY2022Jun 30, 2022146M-2.6%
Q1 FY2022Mar 31, 2022148M-3.1%
Q4 FY2021Dec 31, 2021148M-4.2%
Q3 FY2021Sep 30, 2021149M-5.5%
Q2 FY2021Jun 30, 2021150M-6.7%
Q1 FY2021Mar 31, 2021152M-12.0%
Q4 FY2020Dec 31, 2020154M-13.6%
Q3 FY2020Sep 30, 2020157M-14.7%
Q2 FY2020Jun 30, 2020161M-15.5%
Q1 FY2020Mar 31, 2020173M-12.1%
Q4 FY2019Dec 31, 2019178M-11.0%
Q3 FY2019Sep 30, 2019184M-8.8%
Q2 FY2019Jun 30, 2019190M-8.2%
Q1 FY2019Mar 31, 2019197M-6.9%
Q4 FY2018Dec 31, 2018200M-5.5%
Q3 FY2018Sep 30, 2018202M-4.7%
Q2 FY2018Jun 30, 2018207M-2.3%
Q1 FY2018Mar 31, 2018212M-1.9%
Q4 FY2017Dec 31, 2017212M-2.3%
Q3 FY2017Sep 30, 2017212M–
Q2 FY2017Jun 30, 2017212M–
Q1 FY2017Mar 31, 2017216M–
Q4 FY2016Dec 31, 2016217M–

More Biogen figures

See a number that looks wrong?